URGN UroGen Pharma Ltd.

Fundamentals / CIK 0001668243 / USD

UroGen Pharma Ltd. reported $250.3M in revenue and a net loss of $65.75M for the trailing twelve months ended September 30, 2026 (up 223.9% year over year), with a 91.4% gross margin and a -12.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open URGN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$124.4M$62.21M$0-$152.8MFY 2016 Revenue: $17.53MFY 2016 Net Income: -$1.94M2016FY 2017 Revenue: $8.16MFY 2017 Net Income: -$20.00M2017FY 2018 Revenue: $1.13MFY 2018 Net Income: -$75.66M2018FY 2019 Revenue: $18KFY 2019 Net Income: -$105.1M2019FY 2020 Revenue: $11.80MFY 2020 Net Income: -$128.5M2020FY 2021 Revenue: $48.04MFY 2021 Net Income: -$110.8M2021FY 2022 Revenue: $64.36MFY 2022 Net Income: -$109.8M2022FY 2023 Revenue: $82.71MFY 2023 Net Income: -$102.2M2023FY 2024 Revenue: $90.40MFY 2024 Net Income: -$126.9M2024FY 2025 Revenue: $109.8MFY 2025 Net Income: -$153.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $109.8M $90.40M $82.71M $64.36M $48.04M $11.80M $18K $1.13M $8.16M $17.53M
Cost of Revenue $12.45M $8.88M $9.36M $7.65M $5.16M $1.01M -- $1.80M $600K $28K
Gross Profit $97.34M $81.52M $73.35M $56.70M $42.88M $10.79M $18K -$675K $7.56M $17.50M
Research & Development $67.11M $57.15M $45.61M $52.91M $47.64M $47.31M $49.30M $36.93M $18.70M --
Selling, General & Admin $155.1M $121.2M $93.27M $82.84M $87.53M $90.22M $60.20M -- -- --
Total Operating Expenses -- -- -- -- -- -- $109.5M $76.50M $27.51M --
Operating Income -$124.9M -$96.78M -$65.54M -$79.04M -$92.29M -$126.7M -$109.5M -$77.18M -$19.95M $798K
EBITDA -$124.6M -$96.45M -$64.73M -$78.12M -$91.46M -$126.3M -$109.2M -$76.78M -$19.75M $998K
Interest Income $5.96M $8.90M $2.64M $938K $365K $1.99M $4.62M -- -- --
Income Before Tax -$153.4M -$124.0M -$98.32M -$108.0M -$109.4M -$125.1M -$105.1M -$75.53M -$19.98M -$1.94M
Income Tax Expense $78K $2.83M $3.92M $1.75M $1.45M $3.37M -- $125K $19K --
Net Income -$153.5M -$126.9M -$102.2M -$109.8M -$110.8M -$128.5M -$105.1M -$75.66M -$20.00M -$1.94M
Basic EPS -$3.19 -$2.96 -$3.55 -$4.81 -$4.96 -$5.90 -$5.12 -$4.80 -$2.14 -$1.91
Diluted EPS -- -- -- -- -$4.96 -$5.90 -$5.12 -$4.80 -$2.14 -$1.91
Basic Shares Outstanding 48.1M 42.9M 28.8M 22.8M 22.3M 21.8M 20.5M 15.8M 9.7M 2.3M
Diluted Shares Outstanding -- -- -- -- 22.3M 21.8M 20.5M 15.8M 9.7M 2.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $89.00M $72.46M $50.96M $37.84M $27.48M $24.21M $20.25M $24.57M
Cost of Revenue $7.50M $6.57M $4.14M $3.29M $3.28M $3.55M $2.33M $2.47M
Gross Profit $81.50M $65.88M $46.82M $34.55M $24.20M $20.66M $17.92M $22.09M
Research & Development $25.96M $17.34M $15.60M $14.31M $14.01M $18.91M $19.87M $14.89M
Selling, General & Admin $47.21M $48.44M $51.49M $39.35M $37.58M $43.20M $34.97M $34.86M
Operating Income $8.33M $111K -$20.26M -$19.11M -$27.39M -$41.45M -$36.91M -$27.66M
EBITDA $8.43M $211K -$20.19M -$19.04M -$27.29M -$41.35M -$36.84M -$27.59M
Interest Income $681K $946K $931K $908K $1.18M $1.68M $2.20M $2.81M
Income Before Tax -$446K -$8.72M -$28.35M -$26.64M -$34.40M -$48.92M -$43.45M -$34.86M
Income Tax Expense $1.02M $5.63M -$4.77M -$275K -$1.05M $1.01M $392K $2.65M
Net Income -$1.46M -$14.35M -$23.57M -$26.36M -$33.35M -$49.94M -$43.84M -$37.51M
Basic EPS -$0.03 -$0.28 -$0.47 -- -$0.69 -$1.05 -$0.92 -$0.80
Basic Shares Outstanding 50.6M 50.4M 50.2M -- 48.1M 47.7M 47.4M 47.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $110.7M $172.0M $95.00M $55.41M $44.36M $52.86M $49.69M $101.3M $37.00M $21.36M
Short-Term Investments $49.31M $110.7M $56.16M $44.56M $44.78M $49.15M $97.39M -- $36.00M --
Cash & Short-Term Investments $120.5M $241.7M $141.5M $99.96M $66.88M $102.0M $147.1M $101.3M $73.00M $21.36M
Accounts Receivable, Net $33.08M $20.30M $15.44M $12.70M $11.72M $7.05M -- -- -- $83K
Inventory $16.46M $9.23M $5.67M $4.33M $4.83M $1.96M -- -- $316K $105K
Total Current Assets $186.0M $276.1M $169.2M $128.9M $114.4M $115.6M $148.6M $102.2M $74.47M $22.04M
Property, Plant & Equipment, Net $637K $655K $689K $1.30M $1.97M $2.05M $977K $948K $805K $741K
Long-Term Investments $0 $5.02M $4.50M $0 $675K $1.89M $48.55M -- -- --
Other Non-Current Assets $5.16M $589K $2.04M $2.74M $1.31M $66K $264K $317K $244K $250K
Total Non-Current Assets $14.43M $9.58M $9.12M $6.71M $5.36M $6.39M $53.75M $1.32M $1.08M $1.01M
Total Assets $200.5M $285.7M $178.3M $135.6M $119.7M $122.0M $202.4M $103.6M $75.55M $23.06M
Accounts Payable $12.14M $10.93M $6.51M $5.53M $5.79M $3.27M $4.69M $4.27M $2.84M --
Deferred Revenue (Current) -- -- -- -- -- -- -- -- $650K --
Other Current Liabilities $3.43M $7.95M $3.86M $3.28M $3.33M $1.86M $1.58M -- -- --
Total Current Liabilities $46.42M $45.95M $31.21M $23.92M $22.38M $21.44M $19.48M $13.46M $7.04M $3.14M
Long-Term Debt $122.2M $121.7M $98.55M $97.54M $0 -- -- -- -- --
Total Non-Current Liabilities $259.5M $248.6M $212.3M $201.1M $88.95M $4.21M $2.60M $0 $0 $3.61M
Total Liabilities $305.9M $294.5M $243.5M $225.0M $111.3M $25.65M $22.09M $13.46M $7.04M $6.75M
Total Debt (incl. Leases) $130.1M $125.5M $101.1M $100.1M $1.49M $2.70M $4.19M -- -- --
Common Stock $133K $115K $89K $63K $61K $60K $57K $44K $37K $6.0K
Retained Earnings -$959.7M -$806.2M -$679.3M -$577.1M -$467.3M -$356.5M -$228.0M -$122.9M -$47.21M -$27.21M
Accumulated Other Comp. Income $19K $56K $12K -$107K -$25K $271K $276K -- -- --
Total Stockholders' Equity -$105.5M -$8.80M -$65.21M -$89.36M $8.41M $96.36M $180.3M $90.09M $68.52M $16.31M
Total Equity -$105.5M -$8.80M -$65.21M -$89.36M $8.41M $96.36M $180.3M $90.09M $68.52M $16.31M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $85.56M $79.13M $110.0M $110.7M $90.04M $92.90M $104.0M $172.0M
Short-Term Investments $6.35M $30.16M $39.74M $49.31M $63.79M $83.11M $112.0M $110.7M
Cash & Short-Term Investments $90.50M $108.0M $140.3M $120.5M $127.4M $161.6M $200.4M $241.7M
Accounts Receivable, Net $117.3M $88.76M $55.41M $33.08M $19.70M $19.65M $19.64M $20.30M
Inventory $25.15M $24.59M $20.92M $16.46M $8.34M $7.13M $7.59M $9.23M
Total Current Assets $251.9M $235.4M $237.5M $186.0M $168.5M $196.9M $237.2M $276.1M
Property, Plant & Equipment, Net $588K $597K $616K $637K $695K $688K $627K $655K
Long-Term Investments -- -- -- $0 $380K $4.63M $4.51M $5.02M
Other Non-Current Assets $11.86M $8.76M $7.49M $5.16M $6.76M $801K $371K $589K
Total Non-Current Assets $19.98M $17.16M $16.23M $14.43M $16.50M $11.85M $10.44M $9.58M
Total Assets $271.9M $252.6M $253.7M $200.5M $185.0M $208.7M $247.6M $285.7M
Accounts Payable $17.26M $15.47M $17.21M $12.14M $10.28M $13.56M $14.57M $10.93M
Other Current Liabilities $8.14M $7.62M $5.45M $3.43M $4.96M $4.94M $4.71M $7.95M
Total Current Liabilities $74.03M $61.91M $50.63M $46.42M $42.24M $47.55M $42.00M $45.95M
Long-Term Debt $189.4M $188.7M $189.5M $122.2M $122.1M $122.5M $122.1M $121.7M
Total Non-Current Liabilities $323.1M $323.1M $327.3M $259.5M $258.2M $254.5M $252.1M $248.6M
Total Liabilities $397.1M $385.0M $377.9M $305.9M $300.5M $302.1M $294.1M $294.5M
Total Debt (incl. Leases) $196.3M $196.1M $197.1M $130.1M $129.9M $127.5M $126.4M $125.5M
Common Stock $135K $135K $134K $133K $128K $126K $126K $115K
Retained Earnings -$999.1M -$997.6M -$983.3M -$959.7M -$933.4M -$900.0M -$850.1M -$806.2M
Accumulated Other Comp. Income -$1.0K -$2.0K $8.0K $19K $23K $6.0K $14K $56K
Total Stockholders' Equity -$125.2M -$132.4M -$124.3M -$105.5M -$115.4M -$93.38M -$46.46M -$8.80M
Total Equity -$125.2M -$132.4M -$124.3M -$105.5M -$115.4M -$93.38M -$46.46M -$8.80M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$153.5M -$126.9M -$102.2M -$109.8M -$110.8M -$128.5M -$105.1M -$75.66M -$20.00M -$1.94M
Depreciation & Amortization $307K $329K $802K $924K $831K $416K $300K $400K $200K $200K
Stock-Based Compensation $11.96M $13.11M $9.34M $10.58M $23.11M $28.02M $29.97M $30.64M $6.30M $1.97M
Change in Receivables -$12.78M -$4.86M -$2.74M -$987K -$4.67M -$7.05M -- -- $83K -$83K
Change in Inventory -$7.24M -$3.55M -$1.35M -$362K -$2.87M -$1.96M -- $316K -$211K -$105K
Operating Cash Flow -$162.4M -$96.77M -$76.38M -$87.56M -$84.89M -$105.9M -$71.02M -$37.33M -$9.57M $4.19M
Capital Expenditure -$289K -$295K -$194K -$254K -$752K -$1.22M -$325K -$560K -$271K -$695K
Free Cash Flow -$162.7M -$97.06M -$76.57M -$87.81M -$85.64M -$107.1M -$71.34M -$37.89M -$9.84M $3.49M
Purchases of Investments -$77.40M -$128.0M -$49.83M -$63.01M -$51.90M -$29.69M -$197.7M -- -$36.00M --
Sales & Maturities of Investments -- -- -- $64.32M $56.72M $124.1M -- -- -- --
Investing Cash Flow $61.56M -$20.61M -$953K $1.06M $4.07M $93.24M -$145.6M $35.29M -$36.28M -$719K
Common Stock Issued $39.80M $151.2M $67.36M $0 $0 $15.85M $161.7M $64.23M $60.84M --
Financing Cash Flow $39.92M $194.6M $116.9M $97.13M $72.32M $16.53M $165.2M $66.42M $61.59M -$9.0K
Net Change in Cash -$60.97M $77.24M $39.60M $10.63M -$8.50M $3.88M -$51.36M $64.37M $15.74M $3.46M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.46M -$14.35M -$23.57M -$26.36M -$33.35M -$49.94M -$43.84M -$37.51M
Depreciation & Amortization $100K $100K $75K $75K $100K $100K $72K $68K
Stock-Based Compensation $6.25M $5.33M $4.63M $3.13M $3.03M $2.73M $3.07M $3.30M
Change in Receivables -$28.53M -$33.34M -$22.33M -$13.38M -$54K -$11K $664K $2.50M
Change in Inventory -$561K -$3.67M -$4.46M -$8.12M -$1.21M $462K $1.64M -$1.63M
Operating Cash Flow -$15.20M -$33.01M -$45.32M -$38.33M -$42.27M -$39.83M -$42.02M -$13.62M
Capital Expenditure -$72K -$60K -$54K -$17K -$87K -$141K -$44K -$115K
Free Cash Flow -$15.27M -$33.07M -$45.37M -$38.34M -$42.36M -$39.97M -$42.07M -$13.73M
Purchases of Investments $0 $0 -$24.78M -$539K -$8.72M -$1.79M -$66.35M -$9.23M
Investing Cash Flow $19.85M $1.67M -$20.69M $27.72M $31.40M $28.41M -$25.96M $60.62M
Common Stock Issued -- -- $0 $31.83M $7.97M -$4.0K $4.0K $0
Financing Cash Flow $1.78M $500K $65.20M $31.32M $8.27M $296K $34K $71K
Net Change in Cash $6.43M -$30.83M -$800K $20.71M -$2.60M -$11.12M -$67.95M $47.07M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 88.7% 90.2% 88.7% 88.1% 89.3% 91.4% 100.0% -59.8% 92.6% 99.8%
Operating Margin -113.7% -107.1% -79.2% -122.8% -192.1% -1074.2% -608211.1% -6842.2% -244.5% 4.6%
Net Profit Margin -139.8% -140.4% -123.6% -170.6% -230.7% -1088.9% -584144.4% -6707.2% -245.2% -11.1%
Return on Equity (ROE) -- -- -- -- -1317.2% -133.3% -58.3% -84.0% -29.2% -11.9%
Return on Assets (ROA) -76.6% -44.4% -57.3% -80.9% -92.5% -105.3% -52.0% -73.1% -26.5% -8.4%
Current Ratio 4.01x 6.01x 5.42x 5.39x 5.11x 5.39x 7.63x 7.59x 10.59x 7.03x
Quick Ratio 3.65x 5.81x 5.24x 5.21x 4.90x 5.30x 7.55x 7.52x 10.54x 6.99x
Debt to Equity -- -- -- -- 0.18x 0.03x 0.02x -- -- --
Revenue Growth (YoY) +21.4% +9.3% +28.5% +34.0% +307.2% +65450.0% -98.4% -86.2% -53.5% --
Gross Profit Growth (YoY) +19.4% +11.1% +29.4% +32.2% +297.5% +59844.4% -- -108.9% -56.8% --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -- -2600.0% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -328.4% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -381.6% --
5Y Revenue / Share Growth +321.2% +240351.0% +3906.4% +236.1% -71.7% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 91.4% 90.8% 89.9% 88.7% 88.0% 88.5% 89.7% 90.2%
Operating Margin -12.4% -35.3% -77.0% -113.7% -138.2% -131.1% -117.5% -107.1%
Net Profit Margin -26.3% -51.7% -94.8% -139.8% -170.6% -164.4% -150.7% -140.4%
Return on Assets (ROA) -24.2% -38.7% -52.5% -76.6% -89.0% -74.2% -55.9% -44.4%
Current Ratio 3.40x 3.80x 4.69x 4.01x 3.99x 4.14x 5.65x 6.01x
Quick Ratio 3.06x 3.41x 4.28x 3.65x 3.79x 3.99x 5.47x 5.81x
Revenue Growth (YoY) +223.9% +199.2% +151.6% +54.0% +9.0% +10.8% +7.8% +4.4%
Gross Profit Growth (YoY) +236.7% +218.8% +161.2% +56.4% +6.4% +5.3% +5.1% +4.0%
Source: SEC EDGAR CompanyFacts (CIK 0001668243) · from December 31, 2015 Data through September 30, 2026 · synced Nov 20, 2026, 05:28 UTC · Open in terminal